Effect of synbiotics versus placebo on the prevention of postoperative atrial fibrillation following coronary artery bypass grafting: A double-blind, randomized clinical trial
To assess the effect of synbiotics versus placebo on the prevention of postoperative atrial fibrillation following coronary artery bypass grafting
Design
This is a Phase III double-blind randomized clinical trial with a control group with parallel groups, in which 242 eligible patients will be randomly assigned to the intervention and control groups using block randomization.
Settings and conduct
This study will be conducted at the Farshchian Heart Hospital in Hamadan, involving 242 eligible patients undergoing coronary artery bypass grafting. The patients will be randomly assigned to the intervention and control groups through the block randomization. This trial will be double-blinded.
Participants/Inclusion and exclusion criteria
Inclusion criteria:
Age 18–75 years,
Candidate for elective coronary artery bypass grafting (CABG),
Normal sinus rhythm prior to surgery,
Exclusion criteria:
History of prior cardiac surgery,
Heart block or heart failure,
Mitral or tricuspid valve disease,
Hyperthyroidism,
Patients with a pacemaker,
Pregnancy or breastfeeding
Intervention groups
Intervention group:
Standard treatment plus a synbiotic capsule (Familact 2 Plus), manufactured by Zist Takhmir Pharmaceutical Co., one capsule daily starting two weeks before surgery and continuing for 5 days post-surgery
Control group:
Standard treatment plus a placebo capsule (containing starch), one capsule daily starting two weeks before surgery and continuing for 5 days post-surgery
Main outcome variables
Primary outcome:
Atrial fibrillation
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20120215009014N623
Registration date:2026-09-16, 1405/06/25
Registration timing:prospective
Last update:2026-09-16, 1405/06/25
Update count:0
Registration date
2026-09-16, 1405/06/25
Registrant information
Name
Jalal Poorolajal
Name of organization / entity
Department of Epidemiology & Biostatistics Hamadan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 81 1838 0090
Email address
poorolajal@umsha.ac.ir
Recruitment status
recruiting
Funding source
Expected recruitment start date
2026-10-23, 1405/08/01
Expected recruitment end date
2027-04-20, 1406/01/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of synbiotics versus placebo on the prevention of postoperative atrial fibrillation following coronary artery bypass grafting: A double-blind, randomized clinical trial
Public title
Effect of synbiotics versus placebo on the prevention of postoperative atrial fibrillation following coronary artery bypass grafting
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Age 18–75 years,
Candidate for elective coronary artery bypass grafting (CABG),
Normal sinus rhythm prior to surgery,
Exclusion criteria:
History of prior cardiac surgery,
Heart block or heart failure,
Mitral or tricuspid valve disease,
Hyperthyroidism,
Patients with a pacemaker,
Pregnancy or breastfeeding
Age
From 18 years old to 75 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Outcome assessor
Sample size
Target sample size:
242
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, random assignment of patients to the intervention and control groups will be carried out using block randomization. To achieve this, four sheets of paper will be prepared - two with the name of the intervention and two with the name of the control. These paper sheets will be pooled and placed in a container. Patients will be selected one at a time without replacement, and for each patient, a paper sheet will be randomly drawn from the container. After each draw, the paper sheets will be returned to the container, and the process will be repeated until the desired sample size is reached.
Blinding (investigator's opinion)
Double blinded
Blinding description
Both the medications and placebos will have the same shape. Consequently, patients will remain unaware of the type of intervention they receive. Moreover, the randomization process will be conducted by a separate individual from the one who examines the patients, ensuring that the examining person remains unaware of the intervention. Therefore, the trial will be conducted as a double-blind study.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Hamadan University of Medical Sciences
Street address
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences, Fahmideh Ave
City
Hamadan
Province
Hamadan
Postal code
6517838695
Approval date
2026-09-12, 1405/06/21
Ethics committee reference number
IR.UMSHA.REC.1405.460
Health conditions studied
1
Description of health condition studied
Atrial fibrillation
ICD-10 code
I48.91
ICD-10 code description
Unspecified atrial fibrillation
Primary outcomes
1
Description
Atrial fibrillation
Timepoint
On the first, second, third, fourth, and fifth days after surgery
Method of measurement
Using a monitoring device
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: Standard treatment plus a synbiotic capsule (Familact 2 Plus), manufactured by Zist Takhmir Pharmaceutical Co., one capsule daily starting two weeks before surgery and continuing for 5 days post-surgery
Category
Treatment - Drugs
2
Description
Control group: Standard treatment plus a placebo capsule (containing starch), one capsule daily starting two weeks before surgery and continuing for 5 days post-surgery
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Farshchian Heart Hospital in Hamadan
Full name of responsible person
Dr. Fatemeh Rasouli
Street address
Farshchian Heart Hospital, Fahmideh Ave.
City
Hamadan
Province
Hamadan
Postal code
6517838695
Phone
+98 81 3838 1740
Email
fateme91.rasouli@gmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Dr. Alireza Soltanian
Street address
Hamadan University of Medical Sciences, Fahmideh Ave
City
Hamadan
Province
Hamadan
Postal code
6517838695
Phone
+98 81 3838 0717
Email
info.research@umsha.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Hamedan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Dr. Fatemeh Rasouli
Position
Cardiology Resident
Latest degree
Medical doctor
Other areas of specialty/work
Cardiology
Street address
School of Medicine, Hamadan University of Medical Sciences, Fahmideh Ave.
City
Hamadan
Province
Hamadan
Postal code
6517838695
Phone
+98 81 3838 0572
Email
fateme91.rasouli@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Dr. Nakisa Khansari
Position
Cardiologist
Latest degree
Medical doctor
Other areas of specialty/work
Cardiology
Street address
School of Medicine, Hamadan University of Medical Sciences, Fahmideh Ave.
City
Hamadan
Province
Hamadan
Postal code
6517838695
Phone
+98 81 3838 0572
Email
n_kh_80@yahoo.com
Person responsible for updating data
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Dr. Jalal Poorolajal
Position
Professor of Epidemiology
Latest degree
Ph.D.
Other areas of specialty/work
Epidemiology
Street address
School of Public Health, Hamadan University of Medical Sciences, Fahmideh Ave
City
Hamadan
Province
Hamadan
Postal code
6517838695
Phone
+98 81 3838 0090
Email
poorolajal@umsha.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available